Allurion Technologies Inc. (ALUR)

Market Cap	18.94M
Revenue (ttm)	28.30M
Net Income (ttm)	-24.36M
Shares Out	7.46M
EPS (ttm)	-5.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	112,436
Open	2.500
Previous Close	2.580
Day's Range	2.300 - 2.648
52-Week Range	2.150 - 22.245
Beta	-0.49
Analysts	Strong Buy
Price Target	22.83 (+798.82%)
Earnings Date	Aug 13, 2025

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies In...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 137
• Stock Exchange: NYSE
• Ticker Symbol: ALUR
• Website: https://www.allurion.com

Financial Performance

In 2024, Allurion Technologies's revenue was $32.11 million, a decrease of -39.94% compared to the previous year's $53.47 million. Losses were -$26.15 million, -68.23% less than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for ALUR stock is "Strong Buy." The 12-month stock price target is $22.83, which is an increase of 798.82% from the latest price.

Price Target

$22.83

(798.82% upside)

Analyst Consensus: Strong Buy